» Articles » PMID: 28964260

Factors Associated with Hospitalization in Bronchiectasis Exacerbations: a One-year Follow-up Study

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2017 Oct 2
PMID 28964260
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bronchiectasis (BE) is a chronic structural lung disease with frequent exacerbations, some of which require hospital admission though no clear associated factors have been identified. We aimed to evaluate factors associated with hospitalization due to exacerbations during a 1-year follow-up period.

Methods: A prospective observational study was performed in patients recruited from specialized BE clinics. We considered all exacerbations diagnosed and treated with antibiotics during a follow-up period of 1 year. The protocol recorded baseline variables, usual treatments, Bronchiectasis Severity Index (BSI) and FACED scores, comorbid conditions and prior hospitalizations.

Results: Two hundred and 65 patients were recruited, of whom 162 required hospital admission during the follow-up period. Independent risk factors for hospital admission were age, previous hospitalization due to BE, use of proton pump inhibitors, heart failure, FACED and BSI, whereas pneumococcal vaccination was a protective factor. The area under the receiver operator characteristic curve (AUC) was 0.799 for BSI model was 0.799, and 0.813 for FACED model.

Conclusions: Previous hospitalization, use of proton pump inhibitors, heart failure along with BSI or FACED scores is associated factors for developing exacerbations that require hospitalization. Pneumococcal vaccination was protective. This information may be useful for the design of preventive strategies and more intensive follow-up plans.

Citing Articles

Respiratory Pathology and Cardiovascular Diseases: A Scoping Review.

Campos-Rodriguez F, Chiner E, de la Rosa-Carrillo D, Garcia-Cosio B, Hernadez-Hernandez J, Jimenez D Open Respir Arch. 2025; 7(1):100392.

PMID: 39758960 PMC: 11696865. DOI: 10.1016/j.opresp.2024.100392.


The impact of cardiovascular events in bronchiectasis: a systematic review and meta-analysis.

Gramegna A, Barone I, Alicandro G, Sotgiu G, Bellofiore A, Colombo C ERJ Open Res. 2024; 10(5).

PMID: 39351390 PMC: 11440384. DOI: 10.1183/23120541.01032-2023.


Systemic immune-inflammation index in predicting hospitalized bronchiectasis exacerbation risks and disease severity.

Kwok W, Tam T, Lam D, Ip M, Man Ho J J Thorac Dis. 2024; 16(5):2767-2775.

PMID: 38883640 PMC: 11170410. DOI: 10.21037/jtd-23-1392.


Effects of Probiotics on Clinical Manifestations of Bronchiectasis: A Randomized, Triple Blinded, Placebo-Controlled Clinical Trial.

Alavi Foumani A, Jafari A, Tangestani Nejad A, Jafarinejhad A, Ziyapour S, Keivanlou M Tanaffos. 2024; 22(2):221-229.

PMID: 38628883 PMC: 11016918.


COPD Assessment Test and risk of readmission in patients with bronchiectasis: a prospective cohort study.

Wang J, Chen X, He S, Li J, Ma T, Liu L ERJ Open Res. 2024; 10(2).

PMID: 38500792 PMC: 10945388. DOI: 10.1183/23120541.00867-2023.


References
1.
Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163(5):1256-76. DOI: 10.1164/ajrccm.163.5.2101039. View

2.
Chalmers J . Bronchiectasis and COPD Overlap: A Case of Mistaken Identity?. Chest. 2017; 151(6):1204-1206. DOI: 10.1016/j.chest.2016.12.027. View

3.
Ford E . Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011. Chest. 2014; 147(4):989-998. PMC: 4589247. DOI: 10.1378/chest.14-2146. View

4.
Lambert A, Lam J, Paik J, Ugarte-Gil C, Drummond M, Crowell T . Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One. 2015; 10(6):e0128004. PMC: 4456166. DOI: 10.1371/journal.pone.0128004. View

5.
Chalmers J, Aliberti S, Blasi F . Management of bronchiectasis in adults. Eur Respir J. 2015; 45(5):1446-62. DOI: 10.1183/09031936.00119114. View